VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Lloyd, Pamela G ^a   Prior, Barry M ^a   Li, Han ^a   Yang, Hsiao T ^a   Terjung, Ronald L ^a,b,c,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

F1t; Kinase insert domain containing receptor; Receptor tyrosine kinase inhibition; Treadmill running; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; FEEDING; FEMORAL ARTERY; GASTROCNEMIUS MUSCLE; IC 50; MALE; MUSCLE BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR BLOCKING; SURFACE PROPERTY; TREADMILL EXERCISE;

ANIMALS; CAPILLARIES; COLLATERAL CIRCULATION; EXERTION; GENE EXPRESSION; KIDNEY; LIGATION; MALE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHYSICAL CONDITIONING, ANIMAL; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRIAZOLES;

EID: 12344330190     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00786.2004     Document Type: Article

References (57)

1. Amaral SL, Linderman JR, Morse MM, and Greene AS. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 8: 57-67, 2001.
2. Amaral SL, Papanek PE, and Greene AS. Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. Am J Physiol Heart Circ Physiol 281: H1163-H1169, 2001.
3. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, and Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183-2189, 1994.
4. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, and Wagner PD. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol 81: 355-361, 1996.
5. Brown MD and Hudlicka O. Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6: 1-14, 2003.
6. Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, and Koh GY. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20: 2573-2578, 2000.
7. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, Annex B, Peters K, and Isner JM. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99: 3188-3198, 1999.
8. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, and Isner JM. Mouse model of angiogenesis. Am J Pathol 152: 1667-1679, 1998.
9. Deindl E, Buschmann I, Hoefer IE, Podzuweit T, Boengler K, Vogel S, van R, N, Fernandez B, and Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 89: 779-786, 2001.
10. Egginton S, Hudlicka O, Brown MD, Walter H, Weiss JB, and Bate A. Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle. J Appl Physiol 85: 2025-2032, 1998.
11. Ferrara N, Gerber HP, and LeCouter J. The biology of VEGF and its receptors. Nat Med 9: 669-676, 2003.
12. Gavin TP and Wagner PD. Effect of short-term exercise training on angiogenic growth factor gene responses in rats. J Appl Physiol 90: 1219-1226, 2001.
13. 121 gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 102: 565-571, 2000.
14. Gustafsson T, Puntschart A, Kaijser L, Jansson E, and Sundberg CJ. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 276: H679-H685, 1999.
15. Hang J, Kong L, Gu JW, and Adair TH. VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol Heart Circ Physiol 269: H1827-H1831, 1995.
16. Hennequin LF, Stokes ES, Thomas AP, Johnstone C, Ple PA, Ogilvie DJ, Dukes M, Wedge SR, Kendrew J, and Curwen JO. Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. J Med Chem 45: 1300-1312, 2002.
17. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, and Cook JJ. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 49: 618-625, 2001.
18. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, and Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 49: 609-617, 2001.
19. Ito WD, Arras M, Scholz D, Winkler B, Htun P, and Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol Heart Circ Physiol 273: H1255-H1265, 1997.
20. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
21. Lloyd PG, Prior BM, Yang HT, and Terjung RL. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol 284: H1668-H1678, 2003.
22. Lloyd PG, Yang HT, and Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ Physiol 281: H2528-H2538, 2001.
23. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dwerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, and Carmeleit P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and artherosclerosis by anti-Flt1. Nat Med 8: 831-840, 2002.
24. Mackie BG and Terjung RL. Blood flow to different skeletal muscle fiber types during contraction. Am J Physiol Heart Circ Physiol 245: H265-H275, 1983.
25. Matsunage T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, and Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 102: 3098-3103, 2000.
26. Milkiewicz M, Hudlicka O, Verhaeg J, Egginton S, and Brown MD. Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity. Clin Sci (Lond) 105: 473-482, 2003.
27. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, and Clauss M. VEGFR-1-selective VEGF homologue PlGF is arteriogenic evidence for a monocyte-medicated mechanism. Circ Res 92: 378-385, 2003.
28. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH, and Terjung RL. Time course of changes in collateral blood flow, and isolated vessel size and gene expression following femoral artery occlusion in the rat. Am J Physiol Heart Circ Physiol. First published July 22, 2004; doi: 10.1152/ajpheart.00398. 2004.
29. Prior BM, Yang HT, and Terjung RL. What makes vessels grow with exercise training? J Appl Physiol 97: 1119-1128, 2004.
30. Quinn TP, Peters KG, De Vries C, Ferrara N, and Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537, 1993.
31. Richardson RS, Wagner H, Mudaliar SR, Saucedo E, Henry R, and Wagner PD. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol 279: H772-H778, 2000.
32. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S, Hansen FM, Hudlicka O, and Haas TL. Differential involvement of MMP-2 and VEGF during muscle stretch- versus shear stress-induced angiogenesis. Am J Physiol Heart Circ Physiol 283: H1430-H1438, 2002.
33. Scholz D, Ito W, Fleming I, Deindl E, Souer A, Wiesnet M, Busse R, Schaper J, and Schaper W. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 436: 257-270, 2000.
34. Seligman AM, Heymann H, and Barrnett RJ. The histochemical demonstration of alkaline phosphatase activity with indoxyl phosphate. J Histochem Cytochem 2: 441-442, 1954.
35. Shweiki D, Itin A, Soffer D, and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
36. Staalesen T, Risberg B, and Mattsson E. The kinase insert domain-contraining receptor (KDR) is regulated by shear stress. Scand Cardiovasc J 36: 368-372, 2002.
37. Tang K, Breen EC, Gerber HP, Ferrara N, and Wagner PD. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18: 63-69, 2004.
38. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, and Tedgui A. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 20: 120-126, 2000.
39. Unthank JL, Nixon JC, and Dalsing MC. Nitric oxide maintains dilation of immature and mature collaterals in rat hindlimb. J Vasc Res 33: 471-479, 1996.
40. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, and Schaper W. Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49: 543-553, 2001.
41. 2 max. Exerc Sport Sci Rev 28: 10-14, 2000.
42. Wang H and Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83: 832-840, 1998.
43. Wang Y, Miao H, Li S, Chen KD, Li YS, Yuan S, Shyy JY, and Chien S. Interplay between integrins and FLK-1 in shear stress-induced signaling. Am J Physiol Cell Physiol 283: C1540-C1547, 2002.
44. Ward JE and Angus JA. Collateral development and angiogenesis after major artery ligation does not alter hindquarter vascular reactivity in conscious rabbits. J Cardiovasc Pharmacol 26: 96-106, 1995.
45. Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Curwen JO, Hennequin LF, Thomas AP, Stokes ES, Curry B, Richmond GH, and Wadsworth PF. ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. Cancer Res 60: 970-975, 2000.
46. Woodman CR, Muller JM, Rush JWE, Laughlin MH, and Price EM. Flow regulation of ecNOS and Cu/Zn SOD mRNA expression in porcine coronary arterioles. Am J Physiol Mean Circ Physiol 276: H1058-H1063, 1999.
47. Yang HT, Deschenes MR, Ogilvie RW, and Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res 79: 62-69, 1996.
48. Yang HT, Feng Y, Allen LA, Protter A, and Terjung RL. Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency. Am J Physiol Heart Circ Physiol 278: H1966-H1973, 2000.
49. Yang HT, Laughlin MH, and Terjung RL. Prior exercise training increases collateral-dependent blood flow in rats after acute femoral artery occlusion. Am J Physiol Heart Circ Physiol 279: H1890-H1897, 2000.
50. Yang HT, Ogilvie RW, and Terjung RL. Peripheral adaptations in trained aged rats with femoral artery stenosis. Circ Res 74: 235-243, 1994.
51. Yang HT, Ogilvie RW, and Terjung RL. Heparin increases exercise-induced collateral blood flow in rats with femoral artery ligation. Circ Res 76: 448-456, 1995.
52. Yang HT, Ogilvie RW, and Terjung RL. Training increases collateral-dependent muscle blood flow in aged rats. Am J Physiol Heart Circ Physiol 268: H1174-H1180, 1995.
53. Yang HT, Ogilvie RW, and Terjung RL. Exercise training enhances basic fibroblast growth factor-induced collateral blood flow. Am J Physiol Heart Circ Physiol 274: H2053-H2061, 1998.
54. Yang HT, Ren J, Laughlin MH, and Terjung RL. Prior exercise training produces NO-dependent increases in collateral blood flow after acute arterial occlusion. Am J Physiol Heart Circ Physiol 282: H301-H310, 2002.
55. Yang HT and Terjung RL. Angiotensin converting enzyme inhibition increases collateral-dependent muscle blood flow. J Appl Physiol 75: 452-457, 1993.
56. 121- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 280: H1097-H1104. 2001.
57. Zhou AL, Egginton S, Brown MD, and Hudlicka O. Capillary growth in overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural study. Anat Rec 252: 49-63, 1998.